Longeveron Inc. (LGVN) stock
LGVNNasdaqPharmaceutical PreparationsFiscal year ends December 31
$1.92−0.19 (-9.00%)
Close on Nov 18, 2026Market cap $61.21MP/E –Yield –
Longeveron price to sales ratio
The price-to-sales ratio is market cap divided by revenue over the trailing twelve months.
Longeveron's price to sales ratio was 92.5× on Jan 31, 2024.
Price to Sales Ratio at the end of each year
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| 2024 | Jan 31, 2024 | 92.5× | −140.9 |
| 2023 | Dec 29, 2023 | 233.4× | +58.3 |
| 2021 | Apr 30, 2021 | 175.1× | – |
See a number that looks wrong?